Using Noltrex^®Vet for the Thoroughbred Racehorse

Note:  June 13, 2022 – Nucleus ProVets is aware of the proposed HISA regulations regarding the timelines for use of polyacrylamide hydrogels.  To discuss these regulations further please contact our Veterinary Director, Craig T. Roberts, DVM, at craig.roberts@nucleusprovets.com.

Joint injections should be predictable and planned events, not last-minute problems at a critical time in a horse’s racing career. Similarly, unreliable responses to joint therapy are a major source of frustration when a training program is built on dependability.

Initially considered a therapy to use when all else failed, Noltrex^®Vet’s dependable results in these impossible situations has led to more veterinarians using it earlier on in the management of equine joint conditions. Adding it to a joint management protocol often minimizes the frequency that other joint therapies require to reliably maintain an equine athlete over time.